Connexin 43 loss is associated with a worse prognosis in MS (Masaki, 2015) and also loss of the ability to propagate vasomotor activity by pericytes in diabetic retinopathy (Ivanova et al., 2017). This evidence concerns the gene GJA1 and myeloid sarcoma.